Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Eur J Cancer. 2022 Sep;173:59-70. doi: 10.1016/j.ejca.2022.06.006. Epub 2022 Jul 18.
Ovarian immature teratoma is a rare subtype of germ cell tumour that can be pure or associated with non-teratomatous germ cell tumour elements and is graded based on extent of the immature neuroectodermal component. Immature teratoma (IT) can also be associated with somatic differentiation in the form of sarcoma, carcinoma, or extensive immature neuroectodermal elements and may produce low levels of serum alpha-fetoprotein. Variable interpretation of these issues underlies diagnostic and management dilemmas, resulting in substantial practice differences between paediatric and adult women with IT. The Malignant Germ Cell International Consortium (MaGIC) convened oncologists, surgeons, and pathologists to address the following crucial clinicopathologic issues related to IT: (1) grading of IT, (2) definition and significance of 'microscopic' yolk sac tumour, (3) transformation to a somatic malignancy, and (4) interpretation of serum tumour biomarkers. This review highlights the discussion, conclusions, and suggested next steps from this clinicopathologic conference.
卵巢未成熟畸胎瘤是一种罕见的生殖细胞肿瘤亚型,可为纯未成熟型或伴非畸胎瘤性生殖细胞肿瘤成分,并根据未成熟神经上皮成分的范围进行分级。未成熟畸胎瘤(IT)也可能以肉瘤、癌或广泛未成熟神经上皮成分的形式伴有体细胞分化,并可能产生低水平的血清甲胎蛋白。这些问题的不同解释是导致诊断和治疗困境的基础,导致儿科和成年 IT 患者之间存在实质性的实践差异。恶性生殖细胞国际联合会(MaGIC)召集肿瘤学家、外科医生和病理学家,以解决与 IT 相关的以下关键临床病理问题:(1)IT 的分级,(2)“显微镜下”卵黄囊瘤的定义和意义,(3)向体细胞恶性肿瘤的转化,以及(4)血清肿瘤标志物的解读。本综述重点介绍了该临床病理会议的讨论、结论和建议的下一步措施。